MedPath

Prevalence of Non Celiac Gluten Sensitivity Among Patients Spontaneously Adherent to Gluten Free Diet

Not Applicable
Conditions
Non Celiac Gluten Sensitivity
Interventions
Other: gluten
Other: gluten free flour
Registration Number
NCT01827566
Lead Sponsor
Università degli Studi di Brescia
Brief Summary

The purpose of this study is to assess the prevalence of Gluten Sensitivity, by a double-blind placebo-controlled challenge with gluten, followed by two months period of Low-FODMAPs (Fermentable Oligosaccharides Disaccharides Monosaccharides And Polyols) diet, in patients spontaneously adherent to gluten free diet because of symptoms upon gluten exposure and in whom diagnosis of Celiac Disease and Wheat Allergy has been ruled out.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Adherence to gluten free diet without medical need
  • Negative Celiac Disease related serology (while on gluten containing diet)
  • Normal villous structure at duodenal biopsy (while on gluten containing diet)
Exclusion Criteria
  • Diagnosis of Celiac Disease
  • Diagnosis of Wheat Allergy
  • Diagnosis of organic gastrointestinal disease
  • Severe concomitant disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
glutengluten10 grams of gluten in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet
gluten free flourgluten free flour10 grams of gluten free flour in each sachet to be dispersed daily on food for ten days, while maintaining a gluten free diet
Primary Outcome Measures
NameTimeMethod
Patient's ability to correctly identify the phase with glutenTime (days) 35

* time 0: start of first challenge (phase A, either with gluten or gluten free flour)

* time 10: end of phase A and start of wash-out period

* time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)

* time 35: end of phase B

Secondary Outcome Measures
NameTimeMethod
Change in symptoms' score (1 to 7 Likert scale) as recorded on a daily diaryFrom Time 0 (days) to 10 and from 25 to 35

* time 0: start of first challenge (phase A, either with gluten or gluten free flour)

* time 10: end of phase A and start of wash-out period

* time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)

* time 35: end of phase B

Changes in serum level of anti-tissue transglutaminases immunoglobulin A (IgA)/immunoglobulin G (IgG) and of anti-gliadin IgA/IgGTime (days) 0, 10, 25, 35

* time 0: start of first challenge (phase A, either with gluten or gluten free flour)

* time 10: end of phase A and start of wash-out period

* time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)

* time 35: end of phase B

Change in Gastrointestinal Rating Score (GSRS) during Challenge with and without glutenTime (days) 0,10, 25, 35

* Time 0: Start of first challenge (phase A, either with gluten or gluten free flour)

* Time 10: end of phase A and start of wash-out period

* Time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)

* Time 35: end of phase B

* At the beginning of Low-FODMAPs diet

* After two months of Low-FODMAPs diet

Change in Fatigue Visual ScaleTime (days) 0, 10, 25, 35

* time 0: start of first challenge (phase A, either with gluten or gluten free flour)

* time 10: end of phase A and start of wash-out period

* time 25: end of wash-out period and start of second challenge (phase B, either with gluten or gluten free flour)

* time 35: end of phase B

Trial Locations

Locations (1)

University and Spedali Civili of Brescia, Unit of Gastroenterology

🇮🇹

Brescia, Italy

© Copyright 2025. All Rights Reserved by MedPath